Published: November 13, 2009
CNS Pharmaceuticals AG Engages 886 AG as Designated Sponsor
AIRMONT, N.Y. - (BUSINESS WIRE) - CNS
PHARMACEUTICALS AG, (C35.F)
a developer and marketer of patented natural nutraceutical products is
pleased to announce that the Company's common shares is sponsored by the
German Securities Trading Bank 886 AG Wertpapier Handelsbank on the
electronic trading platform Xetra. The electronic trading system Xetra
is one the world's most high-performance systems for the trading of
around 300,000 international instruments. Xetra has a market share of
over 90% percent in equity trading and is one of the fastest trading
systems in the world with a round trip time at only two milliseconds.
Financial institutions, securities trading houses and brokers can
participate in Xetra trading. Xetra operates independently of the
trader's location, permitting international participation. In fact, more
than 130 participants from European countries outside Germany trade on
Xetra.
"We are pleased to be sponsored on Xetra, that will enable our growing
international investor base to trade our shares which are listed on the
Deutsche Boerse much easier on one of the world's best high-performance
trading systems," said Samuel Weisberger, President of CNS
PHARMACEUTICALS AG.
CNS
PHARMACEUTICALS AG
This is another step towards the company's goal of establishing itself
as the leading worldwide provider of clinically proven supplements that
support / maintain cognitive and other memory-related brain functions.
The company firmly believes that if you are concerned about maintaining
your mental sharpness, concentration and memory you should be taking MemorA-Z
as the product represents the "next generation" of natural supplements
available on our website www.memora-z.com.
This fact is reinforced by a major study which utilized rigorous
scientific standards such as an up-to-date prospective, double-blind
process, a placebo controlled clinical trial with preset inclusion /
exclusion criteria and outcome variables. This study found that the MemorA-Z
formulation effected statistically significant stabilization in memory
function.
About: CNS PHARMACEUTICALS AG
Based in Zurich, Switzerland, CNS
PHARMACEUTICALS AG is the parent company of its 100%-owned U.S.
subsidiary, CNS PHARMACEUTICALS INC. It trades under the symbol C35
on the Frankfurt Stock Exchange. (http://deutche-boerse.com)
www.cnsinvestor.com
CNS's Scientific Advisory Board includes world renowned scientists Dr.
John Blass and Dr. Robert Shorr. John Blass, MD, Ph.D. was the First
Chairman of the USA Joint Presidential-Congressional Panel on
Alzheimer's disease and Related Disorders. He is Professor Emeritus at
Weill Medical College of Cornell University and has published over 300
articles / studies on understanding and improving brain function with a
focus on the aging. Robert Shorr, Ph.D. is a scientist and entrepreneur
with more than 100 inventions and 150+ technical articles to his credit.
Dr. Shorr is the CEO for Cornerstone Pharmaceuticals which is involved
in developing an anti-cancer drug. Dr. Shorr is a highly respected
member of the biotechnology and pharmaceutical science community.
Information presented in this newsletter contain "forward looking
statements" within the meaning of section 27A of the Securities act of
1933 and section 21B of the Securities Exchange Act of 1934. Any
statements that express or involve discussions with respect to
predictions, expectations, beliefs, plans, projections, objectives,
goals, assumptions or future events or performance are not statements of
historical fact and may be "forward looking statements." Forward looking
statements in this action may be identified through the use of words
such as "projects", "foresee", "expects", "will," "anticipates,"
"estimates," "believes," "understands" or that by statements indicating
certain actions "may," "could," or "might" occur.
CNS PHARMACEUTICALS AG
Samuel Weisberger
877-MEMORA-Z
877-636-6729
Fax:
646-219-7444
Website www.cnsinvestor.com
cnspharmaceuticals@yahoo.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
